Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related services to low-income people, as well as Medicare, federal health insurance for people 65 or older, and some under 65 with certain disabilities or conditions.

“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next cycle of negotiations will continue to strengthen Medicare for generations to come," Chiquita Brooks-LaSure, administrator of the Centers for Medicare & Medicaid Services, said in the news release.

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by introducing floors.

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Concern is growing among Democrats after President Donald Trump reversed some of the former president's executive orders, including efforts to reduce prescription drug costs for Medicare and Medicaid beneficiaries.

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

Original Medicare's cost and coverage change annually. This affects how much you pay and the type of supplementary insurance you may want.

Many people may not know that Medicare has covered acupuncture since 2020 as a treatment for chronic back pain. Still, there are specific guidelines you must follow to benefit from this coverage.

The General Enrollment Period provides an opportunity to make up for a past oversight – the failure to enroll in Part B.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.